\
&
Contact us
\
&
Contact us
Published on | 2 years ago
Programmes Health MissionsThis call is open to scientific leaders in Europe keen to contribute to setting a strategic agenda of research priorities in cancer. This agenda will inform the launch of specific research funding programmes by the Mission on Cancer and will identify use cases to feed the European Federated Cancer Research Data Hub.
To achieve this, experts are encouraged to participate in one or more of the following research areas that have been identified: 1. cancer prevention, 2. early diagnosis, 3. sensitivity and resistance to therapy, 4. pediatric cancer, 5. cancer and ageing, 6. survivorship. Selected participants will be asked to provide input through online questionnaires and will be invited to join a face-to-face meeting in spring 2023, with travel expenses covered by 4.UNCAN.eu.
Interested to join? The necessary information on how to apply can be found here. Deadline for applications is 15 August 2022. Additional information can be found here.
Broader context: The Mission on Cancer Board and the European Beating Cancer Plan launched a pan-European initiative to UNderstand CANcer, UNCAN.eu, with the ultimate goal of “improving the lives of more than 3 million people, living longer and better, by 2030”. In order to define a strategic roadmap for UNCAN.eu, the European Commission has supported the creation of a Coordination and Support Action (CSA), 4.UNCAN.eu, that will identify research programs of priority in translational cancer research.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
